FindMyRecallSubscribe
Class I: serious health riskTerminated

Ultra Zx Dietary Supplement Recall

ULTRA ZX DIETARY SUPPLEMENT (Extracto de Naranjo Amargo 70, Extracto de semilla de Sen 47

Ultra ZX Supplements · Miami, FL

Risk level
Class I
Reported by FDA
May 13, 2015
Recall ID
D-0991-2015
Check your lot numberHow we source this data

Summary

Ultra ZX Supplements recalled Ultra Zx Dietary Supplement starting Mar 10, 2015. The FDA classified it as Class I (serious health risk) and published enforcement report D-0991-2015 on May 13, 2015. Reason: Marketed Without An Approved NDA/ANDA: FDA laboratory analysis confirmed that ULTRA ZX contains undeclared sibutramine and phenolphthalein. Status: Terminated.

Why it was recalled

Marketed Without An Approved NDA/ANDA: FDA laboratory analysis confirmed that ULTRA ZX contains undeclared sibutramine and phenolphthalein

Product description

ULTRA ZX DIETARY SUPPLEMENT (Extracto de Naranjo Amargo 70, Extracto de semilla de Sen 47.6, Lagrima de Coix 42, Almidon Medico 84), 30 capsule bottles, Manufactured and distributed by: Ultra ZX Labs, L.L.C. 2525 SW 3rd Ave Apt 1704 Miami, Florida 33129-2068.

Lot numbers, UPCs & expiration codes

All lots/codes/bottles/packages.

Where it was sold

Nationwide and Puerto Rico Foreign: Spain and Ecuador

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0991-2015
Classification
Class I
Status
Terminated
Recall initiated
Mar 10, 2015
FDA report date
May 13, 2015
Quantity
636 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ultra ZX Supplements

Original FDA data

Every field from FDA enforcement report D-0991-2015, exactly as published.

Show all FDA fields
City
Miami
State
FL
Status
Terminated
Country
United States
Event ID
70661
Address
2525 SW 3rd Ave Apt 1704
Code information
All lots/codes/bottles/packages.
Postal code
33129-2068
Report date
May 13, 2015
Product type
Drugs
Recall number
D-0991-2015
Classification
Class I
Recalling firm
Ultra ZX Supplements
Product quantity
636 bottles
Termination date
Apr 26, 2018
Reason for recall
Marketed Without An Approved NDA/ANDA: FDA laboratory analysis confirmed that ULTRA ZX contains undeclared sibutramine and phenolphthalein
Voluntary / mandated
Voluntary: Firm initiated
Product description
ULTRA ZX DIETARY SUPPLEMENT (Extracto de Naranjo Amargo 70, Extracto de semilla de Sen 47.6, Lagrima de Coix 42, Almidon Medico 84), 30 capsule bottles, Manufactured and distributed by: Ultra ZX Labs, L.L.C. 2525 SW 3rd Ave Apt 1704 Miami, Florida 33129-2068.
Distribution pattern
Nationwide and Puerto Rico Foreign: Spain and Ecuador
Recall initiation date
Mar 10, 2015
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
May 5, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0991-2015, published May 13, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls